See more : FE Battery Metals Corp. (FEMFF) Income Statement Analysis – Financial Results
Complete financial analysis of Nitches Inc. (NICH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nitches Inc., a leading company in the Shell Companies industry within the Financial Services sector.
- Masco Corporation (0JZ1.L) Income Statement Analysis – Financial Results
- Mintech (452200.KQ) Income Statement Analysis – Financial Results
- Latrobe Magnesium Limited (LTRBF) Income Statement Analysis – Financial Results
- Saudi Arabian Oil Company (2222.SR) Income Statement Analysis – Financial Results
- Universal Robina Corporation (UVRBF) Income Statement Analysis – Financial Results
Nitches Inc. (NICH)
About Nitches Inc.
Nitches Inc. wholesales, imports, and distributes clothing and home decor products under its own brand labels and retailer-owned private labels in the United States. It distributes clothing primarily in three categories: women's sleepwear and loungewear, women's sportswear and outerwear, and men's casual wear and performance apparel. The company markets women's sleepwear and loungewear under Princesse tam tam, Derek Rose, Crabtree & Evelyn, Disney Couture, The Anne Lewin Collection, The Claire Murray Collection, and Gossard brands; women's sportswear and outerwear under Adobe Rose, Country Tease, Saguaro, and Southwest Canyon brands; and men's casual wear and performance apparel under Nat Nast, Newport Blue, Dockers, The Skins Game, and ZOIC brands. In addition, it distributes made-to-order candles, candle holders, and other home decorating accessories under the Bill Blass and Newport Blue brands. It sells its branded products to department stores, specialty boutiques, moderate department stores, and national and regional discount department stores and chains; and private label products for retailers and catalogs. It sells its products through a sales network consisting of both in-house sales personnel and independent sale representatives. Nitches Inc. was formerly known as Beebas Creations Inc. and changed its name to Nitches Inc. in July 1992. The company was founded in 1971 and is based in Las Vegas, California.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.22K | 710.00 | 0.00 | 0.00 | 0.00 | 84.94M | 54.83M | 26.32M | 32.18M | 28.44M | 29.59M | 33.78M | 39.47M | 31.50M | 31.00M | 48.40M | 54.40M | 83.80M | 119.30M | 116.20M | 117.30M | 132.30M | 158.00M | 128.60M | 102.40M | 107.60M | 94.00M | 46.60M |
Cost of Revenue | 21.35K | 5.35K | 0.00 | 0.00 | 0.00 | 64.59M | 39.99M | 20.53M | 22.78M | 21.86M | 22.21M | 24.85M | 29.16M | 23.20M | 23.60M | 35.90M | 40.00M | 62.80M | 96.40M | 84.20M | 84.60M | 101.10M | 124.70M | 97.10M | 82.20M | 81.60M | 71.40M | 35.60M |
Gross Profit | -17.13K | -4.64K | 0.00 | 0.00 | 0.00 | 20.36M | 14.85M | 5.79M | 9.40M | 6.58M | 7.38M | 8.93M | 10.32M | 8.30M | 7.40M | 12.50M | 14.40M | 21.00M | 22.90M | 32.00M | 32.70M | 31.20M | 33.30M | 31.50M | 20.20M | 26.00M | 22.60M | 11.00M |
Gross Profit Ratio | -405.54% | -653.38% | 0.00% | 0.00% | 0.00% | 23.97% | 27.08% | 21.98% | 29.20% | 23.15% | 24.92% | 26.42% | 26.13% | 26.35% | 23.87% | 25.83% | 26.47% | 25.06% | 19.20% | 27.54% | 27.88% | 23.58% | 21.08% | 24.49% | 19.73% | 24.16% | 24.04% | 23.61% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 6.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | -5.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 420.81K | 832.18K | 14.17M | 1.00K | 1.00K | 20.62M | 13.76M | 8.18M | 8.39M | 7.66M | 7.13M | 7.31M | 7.40M | 7.30M | 8.40M | 11.90M | 12.50M | 19.80M | 27.90M | 29.70M | 25.20M | 26.00M | 33.10M | 24.20M | 19.60M | 17.60M | 15.10M | 6.50M |
Other Expenses | 5.26K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 420.81K | 833.74K | 14.17M | 1.00K | 1.00K | 20.62M | 13.76M | 8.18M | 8.39M | 7.66M | 7.13M | 7.31M | 7.40M | 7.40M | 8.60M | 12.20M | 12.90M | 20.30M | 29.00M | 30.50M | 25.70M | 26.50M | 33.60M | 24.60M | 20.00M | 17.90M | 15.30M | 6.60M |
Cost & Expenses | 447.42K | 839.09K | 14.17M | 1.00K | 1.00K | 85.20M | 53.75M | 28.71M | 31.17M | 29.52M | 29.35M | 32.17M | 36.56M | 30.60M | 32.20M | 48.10M | 52.90M | 83.10M | 125.40M | 114.70M | 110.30M | 127.60M | 158.30M | 121.70M | 102.20M | 99.50M | 86.70M | 42.20M |
Interest Income | 606.10K | 6.06K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 1.81K | 5.01M | 0.00 | 0.00 | 1.04M | 486.00K | 0.00 | 0.00 | 83.00K | 80.00K | 162.00K | 0.00 | 0.00 | 0.00 | 200.00K | 100.00K | 0.00 | 500.00K | 200.00K | 100.00K | 300.00K | 1.30M | 100.00K | 100.00K | 300.00K | 900.00K | 700.00K |
Depreciation & Amortization | 5.26K | 1.56K | 14.17M | 6.00K | 171.86K | 467.00K | 358.00K | 27.00K | 26.00K | 33.00K | 33.00K | 32.00K | 43.00K | 100.00K | 200.00K | 300.00K | 400.00K | 500.00K | 1.10M | 800.00K | 500.00K | 500.00K | 500.00K | 400.00K | 400.00K | 300.00K | 200.00K | 100.00K |
EBITDA | -215.66K | -830.77K | -5.01M | -1.00K | -1.00K | 206.00K | 1.44M | -2.39M | 1.03M | -1.05M | 260.00K | 1.65M | 2.94M | 1.00M | -1.00M | 600.00K | 1.90M | 1.20M | -5.00M | 2.30M | 7.50M | 5.20M | 200.00K | 7.30M | 600.00K | 8.40M | 7.50M | 4.50M |
EBITDA Ratio | -5,105.68% | -117,263.94% | 0.00% | 0.00% | 0.00% | 0.24% | 2.63% | -10.72% | 3.21% | -3.69% | 0.88% | 4.14% | 7.44% | 2.54% | -3.23% | 0.83% | 2.94% | 2.51% | -4.36% | 1.64% | 3.50% | 3.70% | 2.72% | 5.60% | 6.74% | 7.53% | 7.87% | 9.66% |
Operating Income | -443.20K | -838.38K | -14.17M | -1.00K | -1.00K | -261.00K | 1.08M | -2.39M | 1.01M | -1.08M | 243.00K | 1.61M | 2.91M | 900.00K | -1.20M | 300.00K | 1.50M | 700.00K | -6.10M | 1.50M | 7.00M | 4.70M | -300.00K | 6.90M | 200.00K | 8.10M | 7.30M | 4.40M |
Operating Income Ratio | -10,492.42% | -118,081.97% | 0.00% | 0.00% | 0.00% | -0.31% | 1.98% | -9.08% | 3.13% | -3.79% | 0.82% | 4.78% | 7.38% | 2.86% | -3.87% | 0.62% | 2.76% | 0.84% | -5.11% | 1.29% | 5.97% | 3.55% | -0.19% | 5.37% | 0.20% | 7.53% | 7.77% | 9.44% |
Total Other Income/Expenses | -383.82K | 4.25K | -5.01M | -5.00K | 0.00 | -1.04M | -495.00K | 294.00K | -79.00K | -316.00K | -64.00K | 85.00K | -80.00K | 100.00K | 368.00K | 0.00 | 200.00K | -800.00K | 1.40M | 500.00K | 2.50M | -100.00K | -5.40M | 0.00 | -6.40M | 100.00K | -800.00K | -900.00K |
Income Before Tax | -827.02K | -834.13K | -19.18M | -1.00K | -1.00K | -1.30M | 589.00K | -2.10M | 928.00K | -1.40M | 179.00K | 1.70M | 2.83M | 1.00M | -800.00K | 300.00K | 1.70M | -100.00K | -4.70M | 2.00M | 9.50M | 4.60M | -5.70M | 6.90M | -6.20M | 8.20M | 6.50M | 3.50M |
Income Before Tax Ratio | -19,579.02% | -117,483.66% | 0.00% | 0.00% | 0.00% | -1.53% | 1.07% | -7.96% | 2.88% | -4.91% | 0.60% | 5.03% | 7.17% | 3.17% | -2.58% | 0.62% | 3.13% | -0.12% | -3.94% | 1.72% | 8.10% | 3.48% | -3.61% | 5.37% | -6.05% | 7.62% | 6.91% | 7.51% |
Income Tax Expense | 0.00 | 4.25K | -14.17M | -6.00K | -171.86K | -362.00K | 121.00K | -894.00K | 371.00K | -425.00K | 63.00K | 615.00K | 946.00K | 400.00K | -800.00K | 100.00K | 300.00K | -300.00K | -1.30M | 700.00K | 4.00M | 1.90M | -2.30M | 2.80M | -2.10M | 4.10M | 3.30M | 1.70M |
Net Income | -827.02K | -834.13K | -19.18M | -1.00K | -1.00K | -936.00K | 468.00K | -1.20M | 557.00K | -970.00K | 116.00K | 1.08M | 1.89M | 600.00K | 0.00 | 200.00K | 1.40M | 200.00K | -3.40M | 1.30M | 5.50M | 2.70M | -3.40M | 4.10M | -4.10M | 4.10M | 3.20M | 1.80M |
Net Income Ratio | -19,579.02% | -117,483.66% | 0.00% | 0.00% | 0.00% | -1.10% | 0.85% | -4.56% | 1.73% | -3.41% | 0.39% | 3.21% | 4.78% | 1.90% | 0.00% | 0.41% | 2.57% | 0.24% | -2.85% | 1.12% | 4.69% | 2.04% | -2.15% | 3.19% | -4.00% | 3.81% | 3.40% | 3.86% |
EPS | -255.02 | -0.01 | -0.86 | 0.00 | -10.60 | -0.18 | 0.11 | -0.34 | 0.16 | -0.28 | 0.03 | 0.31 | 0.54 | 0.16 | 0.00 | 0.02 | 0.18 | 0.01 | -0.19 | 0.07 | 0.25 | 0.09 | -0.11 | 0.13 | -0.13 | 0.15 | 0.14 | 0.11 |
EPS Diluted | -255.02 | -0.01 | -0.86 | 0.00 | -10.60 | -0.18 | 0.11 | -0.34 | 0.16 | -0.28 | 0.03 | 0.31 | 0.54 | 0.16 | 0.00 | 0.02 | 0.17 | 0.01 | -0.19 | 0.07 | 0.25 | 0.09 | -0.11 | 0.12 | -0.13 | 0.15 | 0.14 | 0.11 |
Weighted Avg Shares Out | 3.24K | 136.71M | 22.33M | 5.66M | 94.33 | 5.31M | 4.08M | 3.51M | 3.51M | 3.51M | 3.48M | 3.52M | 3.52M | 3.81M | 6.94M | 8.25M | 7.97M | 14.67M | 17.88M | 18.05M | 21.94M | 29.28M | 31.05M | 31.62M | 32.34M | 27.90M | 23.63M | 16.02M |
Weighted Avg Shares Out (Dil) | 3.24K | 136.71M | 22.33M | 5.66M | 94.33 | 5.31M | 4.08M | 3.51M | 3.51M | 3.51M | 3.48M | 3.52M | 3.52M | 4.34M | 6.94M | 8.80M | 8.18M | 15.42M | 17.88M | 18.05M | 21.94M | 30.22M | 31.05M | 33.09M | 32.34M | 27.90M | 23.63M | 16.02M |
![News image](https://images.financialmodelingprep.com/news/nitches-inc-announces-inthezone-labs-2025-campaign-featuring-wwe-20241205.jpg)
Nitches Inc. Announces InTheZone Labs' 2025 Campaign Featuring WWE Hall of Famer Kurt Angle, Launching a New Era of Innovation in Nutraceuticals
![News image](https://images.financialmodelingprep.com/news/inthezone-labs-progresses-towards-amazon-listing-expands-affiliate-program-20241125.jpg)
InTheZone Labs Progresses Towards Amazon Listing, Expands Affiliate Program, and Shares Promising Phase One Testing Updates
![News image](https://images.financialmodelingprep.com/news/nitches-inc-announces-inthezone-labs-launch-on-shareasale-one-20241114.jpg)
Nitches Inc. Announces InTheZone Labs' Launch on ShareASale, One of the World's Leading Affiliate Networks
![News image](https://images.financialmodelingprep.com/news/nitches-inc-launches-groundbreaking-veteranled-testing-for-inthezone-focused-20241104.jpg)
Nitches Inc Launches Groundbreaking Veteran-Led Testing for InTheZone Focused Extreme, With Promising Early Results
![News image](https://images.financialmodelingprep.com/news/inthezone-labs-expands-network-with-new-distribution-and-affiliate-20241028.jpg)
InTheZone Labs Expands Network With New Distribution and Affiliate Opportunities, Initiates Phase One Testing With Key Influencers
![News image](https://images.financialmodelingprep.com/news/nitches-inc-unveils-inthezone-focused-extreme-a-premium-supplement-20241023.jpg)
Nitches, Inc. Unveils InTheZone Focused Extreme: A Premium Supplement for Enhanced Focus and Cognitive Performance
![News image](https://images.financialmodelingprep.com/news/nitches-inc-drives-innovation-with-inthezone-labs-groundbreaking-phase-20241021.jpg)
Nitches, Inc. Drives Innovation With InTheZone Labs' Groundbreaking Phase One Testing
![News image](https://images.financialmodelingprep.com/news/nitches-inc-launches-inthezone-focused-youth-americanmade-supplementto-enhance-20241014.jpg)
Nitches, Inc. Launches InTheZone Focused Youth American-Made Supplement to Enhance Focus and Cognitive Health in Adolescents and Young Adults
![News image](https://images.financialmodelingprep.com/news/nitches-inc-launches-new-vertical-with-americanmade-bioceutical-company-20241009.jpg)
Nitches, Inc. Launches New Vertical With American-Made Bioceutical Company, Introducing InTheZone Labs
![News image](https://images.financialmodelingprep.com/news/nitches-inc-to-launch-new-website-and-breakthrough-bioceutical-20241007.jpg)
Nitches, Inc. to Launch New Website and Breakthrough Bioceutical Product Line This Wednesday
Source: https://incomestatements.info
Category: Stock Reports